Skip to main content
. 2024 Dec 28;14:31396. doi: 10.1038/s41598-024-82994-4

Fig. 2.

Fig. 2

MASLD prevalence (A) and metabolic dysfunctions distribution (B) based on MAR quartile. MAR Monocytes to Apolipoprotein A1 ratio, MASLD Metabolic dysfunction-associated fatty liver disease.